AWH Logo

Aspira Women's Health Inc. (AWH) 

NASDAQ
Market Cap
$8.76M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
280 of 950
Rank in Industry
14 of 52

Largest Insider Buys in Sector

AWH Stock Price History Chart

AWH Stock Performance

About Aspira Women's Health Inc.

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.

Insider Activity of Aspira Women's Health Inc.

Over the last 12 months, insiders at Aspira Women's Health Inc. have bought $142,935 and sold $0 worth of Aspira Women's Health Inc. stock.

On average, over the past 5 years, insiders at Aspira Women's Health Inc. have bought $2.25M and sold $71,151 worth of stock each year.

Highest buying activity among insiders over the last 12 months: SCHULER JACK W (10 percent owner) — $548,750. Sandford Nicole (President & CEO) — $33,185.

The last purchase of 6,536 shares for transaction amount of $10,000 was made by SCHULER JACK W (10 percent owner) on 2024‑07‑09.

List of Insider Buy and Sell Transactions, Aspira Women's Health Inc.

2024-07-09Purchase10 percent owner
6,536
0.0674%
$1.53$10,000-25.91%
2024-05-31PurchaseChief Executive Officer
9,493
0.1549%
$2.42$22,973-63.20%
2024-01-26Purchase10 percent owner
28,500
0.6724%
$3.50$99,750-75.71%
2024-01-26PurchasePresident & CEO
2,400
0.0688%
$4.25$10,212-75.71%
2023-12-06SaleSecretary & General Counsel
980
0.0223%
$3.37$3,303-38.36%
2023-12-06PurchasePresident & CEO
5,000
0.1133%
$3.36$16,800-38.36%
2023-09-08PurchaseChief Financial Officer
2,246
0.0651%
$4.30$9,658-18.52%
2023-07-24Purchase10 percent owner
181,800
3.3703%
$2.75$499,950+41.43%
2023-07-24PurchasePresident & CEO
12,563
0.3371%
$3.98$50,001+41.43%
2023-07-24Purchasedirector
6,281
0.1685%
$3.98$24,998+41.43%
2023-07-24Purchasedirector
3,769
0.1011%
$3.98$15,001+41.43%
2023-07-24Purchasedirector
3,769
0.1011%
$3.98$15,001+41.43%
2023-07-24Purchasedirector
6,281
0.1685%
$3.98$24,998+41.43%
2023-07-24Purchasedirector
8,794
0.2359%
$3.98$35,000+41.43%
2023-07-24Purchasedirector
754
0.0202%
$3.98$3,001+41.43%
2023-07-24PurchaseCSO & COO
628
0.0168%
$3.98$2,499+41.43%
2023-07-24PurchaseGeneral counsel and secretary
754
0.0202%
$3.98$3,001+41.43%
2023-07-24PurchaseChief Financial Officer
754
0.0202%
$3.98$3,001+41.43%
2022-08-25Purchase
266,666
0.6741%
$0.38$100,000-26.00%
2022-08-25Purchase
13,332
$0$0-26.00%

Insider Historical Profitability

672.03%
Sandford NicoleChief Executive Officer
70596
0.4027%
$0.5050+1.54%
SCHULER JACK W10 percent owner
6536
0.0373%
$0.50190<0.0001%
FEINBERG LARRY N10 percent owner
9825289
56.0491%
$0.5030<0.0001%
Schuler Henri George10 percent owner
6047057
34.4959%
$0.50162+5.15%
RATHMANN JAMES Ldirector
4391877
25.0538%
$0.5020
RICH WILLIAM EPresident/Chief Exec. Officer
919119
5.2432%
$0.5003
PHRONESIS PARTNERS L P10 percent owner
493611
2.8158%
$0.5009
Burns James Sdirector
397055
2.265%
$0.5020+23.74%
LAFRANCE JAMES Tdirector
298018
1.7001%
$0.5054+31.39%
GOGGIN ROBERT ST LEGERdirector
243685
1.3901%
$0.5010+30.87%
Palmieri Valerie BarberPresident and CEO
215563
1.2297%
$0.50120+11.05%
Beechey Robert HarryChief Financial Officer
210000
1.198%
$0.5050+54.08%
Grossack Marshall JEVP, Chief Actuary
204860
1.1686%
$0.50110
Dupont Wesley DEVP & General Counsel
203488
1.1608%
$0.5039+0.81%
SCHREIBER DAVIDdirector
185018
1.0554%
$0.5003
PAGE GAIL SChief Executive Officer
139907
0.7981%
$0.5021
Carmilani Scott APresident, CEO and Chairman
139000
0.7929%
$0.50228+0.81%
Severinghaus Carldirector
137094
0.7821%
$0.5013+30.87%
Sharma Ruby
127550
0.7276%
$0.5010
Auerbach Robert Ddirector
121492
0.6931%
$0.5010<0.0001%
DILLARD JOAN HEVP & CFO
113230
0.6459%
$0.50313
RODDY PETER Sdirector
112862
0.6438%
$0.5010+30.87%
Gauthier John JEVP & CIO
66152
0.3774%
$0.5020<0.0001%
Fung Eric TS.V.P & C.S.O
52471
0.2993%
$0.5030<0.0001%
Jodoin Richard EV. Chmn, AWAC(US) & AWNAC
49524
0.2825%
$0.5013
Bell DavidCOO
44717
0.2551%
$0.5008
Weinhoff Samuel Jdirector
41825
0.2386%
$0.5074+6214.96%
HUEBNER BRUCE Adirector
40427
0.2306%
$0.5020+5.91%
Schwartz Eric Sdirector
35000
0.1997%
$0.5010+3%
Cavanaugh Stefanie L.director
34904
0.1991%
$0.5010+41.43%
Jordan Veronica GHdirector
34575
0.1972%
$0.5020+32.58%
D'Orazio FrankPres. Bda & Int'l Ins., AWAC
34525
0.197%
$0.5009
Vos Ellen O'Connordirector
32878
0.1876%
$0.5010+41.43%
PATTERSON MARK Rdirector
32698
0.1865%
$0.5020
Parnell Winfreddirector
31513
0.1798%
$0.5010+41.43%
Redmond John TPres, AWAC (Eur) & AWAC (Rein)
31488
0.1796%
$0.5017
Creech William B.VP, Sales and Marketing
30137
0.1719%
$0.50100<0.0001%
Schoen EricSr VP Finance & CAO
29872
0.1704%
$0.5030+24.54%
Herchuk Jannie Prestridgedirector
23833
0.136%
$0.5010+41.43%
Knight W. GordonPresident, AWACUS & AWNAC
19433
0.1109%
$0.50013
CALLAGHAN MICHAEL Jdirector
17000
0.097%
$0.5005
Kohli AshishVP of Corporate Strategy
13500
0.077%
$0.5010<0.0001%
Sennott John Langton JREVP, Chief Corp. Strat Officer
13452
0.0767%
$0.5010<0.0001%
Fralick Celeste Rachelledirector
12032
0.0686%
$0.5020+41.43%
McElroy John JustinCOO
10456
0.0596%
$0.5006
BRADLEY THOMAS AEVP & CFO
8050
0.0459%
$0.5020+2.41%
de Saint-Aignan Patrickdirector
7820
0.0446%
$0.5040<0.0001%
FERRARA FREDChief Operating Officer
6695
0.0382%
$0.5010+23.74%
Friedman Bartdirector
4204
0.024%
$0.5010
Phan Ryan ThinhCSO & COO
3939
0.0225%
$0.5010+41.43%
Hombeck TorstenChief Financial Officer
3000
0.0171%
$0.5020+11.45%
ALEXANDER STILES BARBARAdirector
2000
0.0114%
$0.5010+37400%
DeFeo Philip Ddirector
2000
0.0114%
$0.5010
VERHOEF MARTIN LSr VP, Sales, Marketing & Ops
0
0%
$0.5001
Merchant Minh HoangSecretary & General Counsel
0
0%
$0.5011+41.43%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.